These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4852201)

  • 1. GLC determination of plasma concentration of phenylbutazone and its metabolite oxyphenbutazone.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1974 Aug; 63(8):1234-9. PubMed ID: 4852201
    [No Abstract]   [Full Text] [Related]  

  • 2. GLC determination of gamma-hydroxyphenylbutazone in plasma.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1974 Nov; 63(11):1751-4. PubMed ID: 4427237
    [No Abstract]   [Full Text] [Related]  

  • 3. Simultaneous determination of phenylbutazone and oxyphenbutazone in plasma by high-speed liquid chromatography.
    Pound NJ; Sears RW
    J Pharm Sci; 1975 Feb; 64(2):284-7. PubMed ID: 1127584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
    Bruce RB; Maynard WR; Dunning LK
    J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of bumadizone, phenylbutazone and oxyphenbutazone in human plasma by high-performance liquid chromatography (author's transl)].
    Spahn H; Mutschler E
    Arzneimittelforschung; 1981; 31(3):495-9. PubMed ID: 6894379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The assay of phenylbutazone in human plasma by a specific and sensitive gas-liquid chromatographic procedure.
    McGilveray IJ; Midha KK; Brien R; Wilson L
    J Chromatogr; 1974 Feb; 89(1):17-22. PubMed ID: 4815964
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation of furosemide, phenylbutazone and oxyphenbutazone in plasma by direct injection onto internal surface reversed-phase columns with systematic optimization of selectivity.
    Pinkerton TC; Perry JA; Rateike JD
    J Chromatogr; 1986 Oct; 367(2):412-8. PubMed ID: 3782354
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys.
    Matthews NS; Peck KE; Taylor TS; Mealey KL
    Am J Vet Res; 2001 May; 62(5):673-5. PubMed ID: 11341383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
    Caturla MC; Cusido E
    J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A supercritical fluid chromatographic method using packed columns for phenylbutazone and oxyphenbutazone in serum, and for phenylbutazone in a dosage form.
    Simmons BR; Jagota NK; Stewart JT
    J Pharm Biomed Anal; 1995 Jan; 13(1):59-64. PubMed ID: 7718635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of phenylbutazone elimination by its metabolite oxyphenbutazone.
    Jähnchen E; Levy G
    Proc Soc Exp Biol Med; 1972 Dec; 141(3):963-5. PubMed ID: 4645785
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening, quantification, and confirmation of phenylbutazone and oxyphenbutazone in equine plasma by liquid chromatography-tandem mass spectrometry.
    You Y; Uboh CE; Soma LR; Guan F; Li X; Rudy JA; Chen J
    J Anal Toxicol; 2009; 33(1):41-50. PubMed ID: 19161668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
    Cheng Z; Welsh E; Nolan A; McKellar QA
    Vet Rec; 1997 Jan; 140(2):40-3. PubMed ID: 9123796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse.
    Lees P; Taylor JB; Higgins AJ; Sharma SC
    J Vet Pharmacol Ther; 1986 Jun; 9(2):204-12. PubMed ID: 3723663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of tobacco on the serum levels and pharmacokinetics of phenylbutazone and oxyphenbutazone].
    Queneau P; Ollagnier M; Decousus H; Perpoint B; Brazier JL; Faucon L
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):293-7. PubMed ID: 6879097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.